CLINDAMYCIN PHOSPHA

The Defense Logistics Agency awarded Contract SPE2DP26F7598 to DMS PHARMACEUTICAL GROUP INC, CAGE code 1UNB0, for the procurement of 2.000 treatment units of CLINDAMYCIN PHOSPHA (NSN 6505012850797) at a total price of $37.30. The contract was awarded on July 14, 2026, and is a delivery order under the master agreement SPE2DX25D9900. Delivery is required by July 29, 2026, to the destination address in Baumholder, Germany, identified as W50YF3, with FOB Destination terms placing all freight cost and risk-of-loss responsibility on the contractor. The item is subject to zero variance in quantity and medical substitution is permitted under the specified RANK identifier. Packaging and marking requirements reference DLAD PROC NOTES C19 and C20, with a Transportation Control Number W50YF361330007 assigned for traceability, though no explicit compliance with MIL-STD-129 or MIL-STD-2073 is stated. The contractor’s CAGE code is 1UNB0 and the manufacturer’s is 9MGE4; no socioeconomic status, size designation, or certification data is provided. No clause listings, attachments, evaluation factors, or point-of-contact details are included in the available documentation. The award is fixed-price, with no options, and invoicing details are unspecified beyond the FOB Contractor payment structure. Performance and acceptance occur at the destination, and no Contracting Officer’s Representative or technical points of contact are identified.